- Published on
Ophthalmology – Anterior Basement Membrane Dystrophy
Anterior basement membrane dystrophy (ABMD) is the most common corneal dystrophy and is also known by several names, including map-dot-fingerprint dystrophy, mare’s tail dystrophy, and Cogan’s microcystic dystrophy. It is characterized by abnormalities in the corneal epithelial basement membrane that lead to irregularities of the corneal surface. Clinically, it is most commonly associated with two distinct presentations: recurrent painful corneal erosions and visual disturbance due to an irregular corneal surface, and management differs depending on which presentation predominates.
ABMD is relatively common, affecting up to 10% of the adult population in the United States, with a higher prevalence in women. It typically presents in the fourth or fifth decade of life and may gradually worsen over time. The condition is usually inherited in an autosomal dominant pattern. It may coexist with other ocular surface disorders, such as Fuchs’ endothelial dystrophy, and can be exacerbated by chronic blepharitis.
The underlying pathophysiology involves abnormalities in the epithelial basement membrane, including thickening, reduplication, and extension into the overlying epithelium. This leads to poor adhesion between the epithelium and underlying layers, as well as entrapment of cellular debris within cyst-like structures. These structural abnormalities result in an irregular corneal surface and predispose the epithelium to recurrent breakdown.
Patients typically present in one of two ways. The first is with recurrent corneal erosions, often characterized by sudden onset of pain upon awakening, accompanied by foreign body sensation, tearing, and photophobia. This occurs because the eyelid adheres to the poorly attached epithelium during sleep and disrupts it when opening. The second presentation involves gradual visual decline due to irregular astigmatism from the abnormal epithelial surface, sometimes accompanied by mild irritation.
On examination, findings vary depending on the presentation. In cases of recurrent erosion, there may be a localized area of loose or absent epithelium along with surrounding characteristic changes of ABMD. In cases presenting with visual disturbance, slit-lamp examination reveals classic map, dot, and fingerprint patterns within the corneal epithelium, often over the visual axis, leading to surface irregularity. Diagnostic evaluation includes visual acuity testing and slit-lamp examination, with corneal topography often demonstrating irregular mires and increased surface irregularity. Anterior segment optical coherence tomography can further delineate epithelial and basement membrane abnormalities. A rigid gas-permeable contact lens trial may help confirm that visual symptoms are due to corneal surface irregularity if vision improves significantly with the lens.
The differential diagnosis depends on the clinical presentation. Painful presentations must be distinguished from other causes of ocular surface irritation such as dry eye disease, infectious or chemical keratitis, trauma, and blepharitis. Visual disturbance must be differentiated from other causes of decreased vision, including cataract, macular disease, optic neuropathy, and other corneal pathologies.
Management is tailored to the presenting symptoms. For recurrent erosions, first-line treatment focuses on aggressive lubrication with artificial tears, gels, or ointments, particularly at bedtime, and advising patients to open their eyes slowly upon waking. Hypertonic saline ointments may be used to reduce epithelial edema. Additional measures include punctal occlusion to improve tear retention and therapeutic bandage contact lenses to protect the corneal surface. Topical nonsteroidal anti-inflammatory drugs and cyclosporine may be used to control inflammation and improve tear production.
For cases that are refractory or recurrent, procedural interventions may be considered. These include mechanical debridement of the epithelium with a diamond-dusted burr, ethanol epitheliectomy, or phototherapeutic keratectomy, all of which aim to improve epithelial adherence and reduce recurrence of erosions.
In patients with visually significant disease, treatment focuses on improving the corneal surface. Superficial keratectomy is commonly performed to remove the abnormal epithelium and irregular basement membrane over the visual axis, allowing regeneration of a smoother epithelial surface. Unlike treatment for erosions, aggressive polishing of Bowman’s layer is generally avoided to reduce the risk of scarring. A bandage contact lens is typically placed postoperatively, and topical antibiotics, steroids, and anti-inflammatory medications are used during healing.
Follow-up is based on symptom recurrence and response to treatment, and interventions may be repeated if necessary. The overall prognosis is excellent for both pain and visual symptoms with appropriate management. However, complications such as secondary infection or subepithelial scarring can occur, particularly following surgical intervention.
Anterior basement membrane dystrophy (ABMD) is the most common corneal dystrophy and is also known by several names, including map-dot-fingerprint dystrophy, mare’s tail dystrophy, and Cogan’s microcystic dystrophy. It is characterized by abnormalities in the corneal epithelial basement membrane that lead to irregularities of the corneal surface. Clinically, it is most commonly associated with two distinct presentations: recurrent painful corneal erosions and visual disturbance due to an irregular corneal surface, and management differs depending on which presentation predominates.
ABMD is relatively common, affecting up to 10% of the adult population in the United States, with a higher prevalence in women. It typically presents in the fourth or fifth decade of life and may gradually worsen over time. The condition is usually inherited in an autosomal dominant pattern. It may coexist with other ocular surface disorders, such as Fuchs’ endothelial dystrophy, and can be exacerbated by chronic blepharitis.
The underlying pathophysiology involves abnormalities in the epithelial basement membrane, including thickening, reduplication, and extension into the overlying epithelium. This leads to poor adhesion between the epithelium and underlying layers, as well as entrapment of cellular debris within cyst-like structures. These structural abnormalities result in an irregular corneal surface and predispose the epithelium to recurrent breakdown.
Patients typically present in one of two ways. The first is with recurrent corneal erosions, often characterized by sudden onset of pain upon awakening, accompanied by foreign body sensation, tearing, and photophobia. This occurs because the eyelid adheres to the poorly attached epithelium during sleep and disrupts it when opening. The second presentation involves gradual visual decline due to irregular astigmatism from the abnormal epithelial surface, sometimes accompanied by mild irritation.
On examination, findings vary depending on the presentation. In cases of recurrent erosion, there may be a localized area of loose or absent epithelium along with surrounding characteristic changes of ABMD. In cases presenting with visual disturbance, slit-lamp examination reveals classic map, dot, and fingerprint patterns within the corneal epithelium, often over the visual axis, leading to surface irregularity. Diagnostic evaluation includes visual acuity testing and slit-lamp examination, with corneal topography often demonstrating irregular mires and increased surface irregularity. Anterior segment optical coherence tomography can further delineate epithelial and basement membrane abnormalities. A rigid gas-permeable contact lens trial may help confirm that visual symptoms are due to corneal surface irregularity if vision improves significantly with the lens.
The differential diagnosis depends on the clinical presentation. Painful presentations must be distinguished from other causes of ocular surface irritation such as dry eye disease, infectious or chemical keratitis, trauma, and blepharitis. Visual disturbance must be differentiated from other causes of decreased vision, including cataract, macular disease, optic neuropathy, and other corneal pathologies.
Management is tailored to the presenting symptoms. For recurrent erosions, first-line treatment focuses on aggressive lubrication with artificial tears, gels, or ointments, particularly at bedtime, and advising patients to open their eyes slowly upon waking. Hypertonic saline ointments may be used to reduce epithelial edema. Additional measures include punctal occlusion to improve tear retention and therapeutic bandage contact lenses to protect the corneal surface. Topical nonsteroidal anti-inflammatory drugs and cyclosporine may be used to control inflammation and improve tear production.
For cases that are refractory or recurrent, procedural interventions may be considered. These include mechanical debridement of the epithelium with a diamond-dusted burr, ethanol epitheliectomy, or phototherapeutic keratectomy, all of which aim to improve epithelial adherence and reduce recurrence of erosions.
In patients with visually significant disease, treatment focuses on improving the corneal surface. Superficial keratectomy is commonly performed to remove the abnormal epithelium and irregular basement membrane over the visual axis, allowing regeneration of a smoother epithelial surface. Unlike treatment for erosions, aggressive polishing of Bowman’s layer is generally avoided to reduce the risk of scarring. A bandage contact lens is typically placed postoperatively, and topical antibiotics, steroids, and anti-inflammatory medications are used during healing.
Follow-up is based on symptom recurrence and response to treatment, and interventions may be repeated if necessary. The overall prognosis is excellent for both pain and visual symptoms with appropriate management. However, complications such as secondary infection or subepithelial scarring can occur, particularly following surgical intervention.
0 Comments
